{"id":"W2801086913","doi":"10.1177/247553030713a00101","title":"Efficacy and Safety of Adalimumab Treatment in Patients with Moderate to Severe Psoriasis: A Double-Blind, Randomized Clinical Trial","year":2007,"lang":"en","type":"article","venue":"Psoriasis Forum","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Abbott (Canada); Probity Medical Research","funders":"Astellas Pharma","keywords":"Adalimumab; Medicine; Psoriasis Area and Severity Index; Psoriasis; Placebo; Internal medicine; Randomized controlled trial; Clinical trial; Gastroenterology; Tumor necrosis factor alpha; Dermatology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003637406,0.001826873,0.004709633,0.0005920711,0.0007896097,0.001394653,0.001027477,0.002968262,0.00778146],"category_scores_gemma":[0.003201663,0.0009066802,0.002134764,0.0005653441,0.001603765,0.001104706,0.0004953256,0.002324884,0.00121818],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006074547,"about_ca_system_score_gemma":0.00139222,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004496415,"about_ca_topic_score_gemma":0.0008710963,"domain_scores_codex":[0.9981467,0.001074387,0.0001586816,0.0003170814,0.0001351469,0.0001679783],"domain_scores_gemma":[0.9981644,0.0005454544,0.0004411572,0.0001525673,0.0001511399,0.0005452669],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9876973,0.004053717,0.0002946566,0.0004725596,0.000438579,0.00001711958,0.00001987082,0.00006224019,0.001031982,0.0000434036,0.0003379546,0.005530496],"study_design_scores_gemma":[0.9800776,0.01866616,0.0005489024,0.00001945164,0.000194915,0.00001508955,0.000005453878,0.0001174172,0.0000862599,0.00005292539,0.0002100595,0.000005723502],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9663639,0.01118053,0.001643519,0.001410482,0.001562595,0.0128461,0.001471949,0.0002704884,0.003250451],"genre_scores_gemma":[0.9696987,0.004803946,0.002936196,0.00224733,0.001554036,0.01418138,0.00110457,0.00003229551,0.003441446],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00778146,"threshold_uncertainty_score":0.02603155,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03118195997106565,"score_gpt":0.3004633896999236,"score_spread":0.2692814297288579,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}